reviews on glp 1 patches Patchie GLP-1 (2025): Honest Look at Results, Complaints and Whether This Weight-Loss Patch Works In the gray world of
Description
1 Dual agonism of GIP and GLP-1 receptors is a promising new approach currently in clinical development for the treatment of diabetes, obesity, and associated complications [1] The incretin effect defines the main physiological role of GIP and GLP-1 GIP and GLP-1 increase insulin secretion following nutrient-induced secretion from the gut (incretin effect): There is a stronger insulin secretion response to oral compared to 'isoglycemic' intravenous glucose administration due to secretion and action of incretin hormones

Jardine, R
doi: 10.3390/biom13061002 [DOI] [PMC free article] [PubMed] [Google Scholar] 135.Saleh MN, Patel MR, Bauer TM, et al

marketed for diabetes as Mounjaro and for weight management under trade names such as Zepbound) Tirzepatide combines GLP-1 and GIP receptor agonism and has shown the largest average weight losses of any medication to date
Patients with T2D commonly have CV risk factors
